Subscribe
Sign in
Home
Podcast
Chat
Business Acumen
QMSR Compliance
Wall of Love
Archive
About
14:03
Case Study: When Underestimating Risk Leads to a Warning Letter
Lessons learned from a recent FDA warning letter highlighting systematic issues with risk analysis, CAPA and design controls.
Jul 7
•
Naveen Agarwal, Ph.D.
5
Share this post
Copy link
Facebook
Email
Notes
More
Medical Device Recalls - Part 1: High Level Overview
A high level overview of 283 Class I recalls of medical devices in the last 3 years.
Jul 2
•
Naveen Agarwal, Ph.D.
3
Share this post
Let's Talk Risk!
Medical Device Recalls - Part 1: High Level Overview
Copy link
Facebook
Email
Notes
More
2
Quick Tip - Use FDA guidance and worksheet for benefit-risk evaluation
Benefit-risk evaluation of a medical device often proves to be challenging in practice. Here is a practical approach and a case study you can apply in…
Jun 30
•
Naveen Agarwal, Ph.D.
2
Share this post
Let's Talk Risk!
Quick Tip - Use FDA guidance and worksheet for benefit-risk evaluation
Copy link
Facebook
Email
Notes
More
Most Popular
View all
ISO 14971 Fundamentals: Characteristics related to safety
Dec 20, 2023
•
Naveen Agarwal, Ph.D.
11
Share this post
Let's Talk Risk!
ISO 14971 Fundamentals: Characteristics related to safety
Copy link
Facebook
Email
Notes
More
5
Medical Device News Update - March 2025
May 7
•
Naveen Agarwal, Ph.D.
2
Share this post
Let's Talk Risk!
Medical Device News Update - March 2025
Copy link
Facebook
Email
Notes
More
Webinar 10: Tips for medical device software risk analysis
Jul 3, 2024
•
Naveen Agarwal, Ph.D.
6
Share this post
Let's Talk Risk!
Webinar 10: Tips for medical device software risk analysis
Copy link
Facebook
Email
Notes
More
2
LTR 102: Collaboration that drives innovation, not delays
Apr 18
4
Share this post
Let's Talk Risk!
LTR 102: Collaboration that drives innovation, not delays
Copy link
Facebook
Email
Notes
More
LTR 82: Tips for Regulatory Success with AI Devices in Radiology
Jan 10
•
Naveen Agarwal, Ph.D.
6
Share this post
Let's Talk Risk!
LTR 82: Tips for Regulatory Success with AI Devices in Radiology
Copy link
Facebook
Email
Notes
More
Medical Device Recalls - Part 1: High Level Overview
Jul 2
•
Naveen Agarwal, Ph.D.
3
Share this post
Let's Talk Risk!
Medical Device Recalls - Part 1: High Level Overview
Copy link
Facebook
Email
Notes
More
2
Case studies
See all
14:03
Case Study: When Underestimating Risk Leads to a Warning Letter
Lessons learned from a recent FDA warning letter highlighting systematic issues with risk analysis, CAPA and design controls.
Jul 7
•
Naveen Agarwal, Ph.D.
5
Share this post
Copy link
Facebook
Email
Notes
More
17:10
Case Study: A Warning Letter Exposes Issues in Risk Analysis
Lessons learned from a recent FDA warning letter highlighting systemic issues in risk analysis, design verification and post-market vigilance for a…
Jun 16
•
Naveen Agarwal, Ph.D.
1
Share this post
Copy link
Facebook
Email
Notes
More
11:22
Case Study: A Promising Device Fails in the Market Due to Usability Issues
5 years after acquiring a promising medical device, a major MedTech discontinued marketing following a Class I recall. Here are a few lessons learned…
Jun 9
•
Naveen Agarwal, Ph.D.
2
Share this post
Copy link
Facebook
Email
Notes
More
3
Webinars
See all
48:31
Webinar 10: Tips for medical device software risk analysis
An overview of key challenges and tips for analyzing the risks of medical device software failures.
Jul 3, 2024
•
Naveen Agarwal, Ph.D.
6
Share this post
Let's Talk Risk!
Webinar 10: Tips for medical device software risk analysis
Copy link
Facebook
Email
Notes
More
2
54:26
Webinar 9: How to set up post-market surveillance
A review of ISO 14971 requirements and practical tips to set up an efficient and effective post-market safety surveillance process for your medical…
May 29, 2024
•
Naveen Agarwal, Ph.D.
3
Share this post
Let's Talk Risk!
Webinar 9: How to set up post-market surveillance
Copy link
Facebook
Email
Notes
More
56:41
Webinar 8: Case study discussion and Q&A
Watch now | A case study about a warning letter for miscalculating risk and a general Q&A session about risk management.
May 1, 2024
•
Naveen Agarwal, Ph.D.
1
Share this post
Let's Talk Risk!
Webinar 8: Case study discussion and Q&A
Copy link
Facebook
Email
Notes
More
Quick tips
See all
Risk management fundamentals
See all
Medtech news
See all
AMA on Risk Management
See all
LTR weekly digests
See all
Let's Talk Risk!
Building competence through content, community and conversations.
Subscribe
Recommendations
The FDA Group's Insider Newsletter
The FDA Group
What the FDA?
Steve Silverman
The Other Consultants: MedTech Quality & Regulatory Insights
Adam Isaacs Rae
Clinical Evaluation Navigator
Hatem Rabeh
Let's Talk Risk!
Subscribe
About
Archive
Recommendations
Sitemap
Share this publication
naveenagarwalphd
Let's Talk Risk!
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts